biliary drainage
Devicepercutaneous transhepatic biliary drainage (PTBD)
NCT Number: NCT01499537
At this time, endoscopic retrograde cholangiopancreatography (ERCP) stay the gold standard method to achieve biliary drainage in case of malignant or benign stricture. When ERCP fail or if the major papilla is not suitable, percutaneous transhepatic biliary drainage (PTBD) is the most commonly used alternative, surgery having higher morbidity and mortality rates, unacceptable especially in palliative situation. Recent developments in interventional endoscopic ultrasonography (EUS) allow new endoluminal approaches to pancreatic-biliary structures, such as cysto-enterostomy or pancreatic-enterostomy. More recently were described the possibility to realize EUS-guided biliary drainage, through the duodenal or the gastric wall. Advantages of the EUS-guided approach are to be realizable even the papilla is not suitable endoscopically (duodenal stricture or post-surgical status) and to allow if necessary extra-tumoral non anatomic drainage (hepaticogastrostomy). This technique is actually an alternative to PTBD. In comparison of the PTBD, EUS-guided route seems to have less morbidity and to avoid external biliary drainage. Indeed, the morbidity rate of the percutaneous biliary drainage and the EUS-guided biliary drainage range respectively from 25 to 35% and from 0 to 23%. However, none study compare prospectively both techniques. Aims of this study are to compare the morbidity rate, feasibility and efficacy of these techniques.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hopital Nord, Marseille, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
percutaneous transhepatic biliary drainage (PTBD)
endoscopic ultrasonography guided biliary drainage through the duodenal or the gastric wall
Time frame: 30 days
Morbidity rate during 30 post-operative days
Time frame: 15 days
decrease of bilirubine > 50%
Time frame: up to 3 days
succes or not of the intervention to obtain bilairy drainage
Time frame: up to 1 month
time between intervention and drain withdrawal
Time frame: 30 days
QLQ-C30 questionnary at inclusion and at D30
Institut Paoli-Calmettes
Other
Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct in Patients With Malignant or Post-operative Jaundice After Failure or Impossibility to Perform Endoscopic Retrograde Cholangiography
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07575789
Hyperbilirubinemia, Jaundice
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT01976936
Brain Diseases, Cardiovascular Diseases
Los Angeles, California, United States
View Trial DetailsNCT02991339
Bilirubinaemia, Digestive System Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT02033096
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
View Trial Details